Table of Contents
Chapter 1 Overview of Hemostatic Forceps
    1.1 Definition of Hemostatic Forceps in This Report
    1.2 Commercial Types of Hemostatic Forceps
        1.2.1 Halstead Mosquito Hemostatic Forceps 
        1.2.2 Kelly and Crile Hemostatic Forceps 
        1.2.3 Rochester-Carmalt Hemostatic Forceps 
    1.3 Downstream Application of Hemostatic Forceps
        1.3.1 Surgical 
        1.3.2 Dissection 
        1.3.3 Dental 
        1.3.4 Laparoscopic 
        1.3.5 Others
    1.4 Development History of Hemostatic Forceps
    1.5 Market Status and Trend of Hemostatic Forceps 2013-2023
        1.5.1 Global Hemostatic Forceps Market Status and Trend 2013-2023
        1.5.2 Regional Hemostatic Forceps Market Status and Trend 2013-2023
Chapter 2 Global Market Status and Forecast by Regions
    2.1 Market Development of Hemostatic Forceps 2013-2017
    2.2 Sales Market of Hemostatic Forceps by Regions
        2.2.1 Sales Volume of Hemostatic Forceps by Regions
        2.2.2 Sales Value of Hemostatic Forceps by Regions
    2.3 Production Market of Hemostatic Forceps by Regions
    2.4 Global Market Forecast of Hemostatic Forceps 2018-2023
        2.4.1 Global Market Forecast of Hemostatic Forceps 2018-2023
        2.4.2 Market Forecast of Hemostatic Forceps by Regions 2018-2023
Chapter 3 Global Market Status and Forecast by Types
    3.1 Sales Volume of Hemostatic Forceps by Types
    3.2 Sales Value of Hemostatic Forceps by Types
    3.3 Market Forecast of Hemostatic Forceps by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
    4.1 Global Sales Volume of Hemostatic Forceps by Downstream Industry
    4.2 Global Market Forecast of Hemostatic Forceps by Downstream Industry
Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry
    5.1 North America Hemostatic Forceps Market Status by Countries
        5.1.1 North America Hemostatic Forceps Sales by Countries (2013-2017)
        5.1.2 North America Hemostatic Forceps Revenue by Countries (2013-2017)
        5.1.3 United States Hemostatic Forceps Market Status (2013-2017)
        5.1.4 Canada Hemostatic Forceps Market Status (2013-2017)
        5.1.5 Mexico Hemostatic Forceps Market Status (2013-2017)
    5.2 North America Hemostatic Forceps Market Status by Manufacturers
    5.3 North America Hemostatic Forceps Market Status by Type (2013-2017)
        5.3.1 North America Hemostatic Forceps Sales by Type (2013-2017)
        5.3.2 North America Hemostatic Forceps Revenue by Type (2013-2017)
    5.4 North America Hemostatic Forceps Market Status by Downstream Industry (2013-2017)
Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry
    6.1 Europe Hemostatic Forceps Market Status by Countries
        6.1.1 Europe Hemostatic Forceps Sales by Countries (2013-2017)
        6.1.2 Europe Hemostatic Forceps Revenue by Countries (2013-2017)
        6.1.3 Germany Hemostatic Forceps Market Status (2013-2017)
        6.1.4 UK Hemostatic Forceps Market Status (2013-2017)
        6.1.5 France Hemostatic Forceps Market Status (2013-2017)
        6.1.6 Italy Hemostatic Forceps Market Status (2013-2017)
        6.1.7 Russia Hemostatic Forceps Market Status (2013-2017)
        6.1.8 Spain Hemostatic Forceps Market Status (2013-2017)
        6.1.9 Benelux Hemostatic Forceps Market Status (2013-2017)
    6.2 Europe Hemostatic Forceps Market Status by Manufacturers
    6.3 Europe Hemostatic Forceps Market Status by Type (2013-2017)
        6.3.1 Europe Hemostatic Forceps Sales by Type (2013-2017)
        6.3.2 Europe Hemostatic Forceps Revenue by Type (2013-2017)
    6.4 Europe Hemostatic Forceps Market Status by Downstream Industry (2013-2017)
Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry
    7.1 Asia Pacific Hemostatic Forceps Market Status by Countries
        7.1.1 Asia Pacific Hemostatic Forceps Sales by Countries (2013-2017)
        7.1.2 Asia Pacific Hemostatic Forceps Revenue by Countries (2013-2017)
        7.1.3 China Hemostatic Forceps Market Status (2013-2017)
        7.1.4 Japan Hemostatic Forceps Market Status (2013-2017)
        7.1.5 India Hemostatic Forceps Market Status (2013-2017)
        7.1.6 Southeast Asia Hemostatic Forceps Market Status (2013-2017)
        7.1.7 Australia Hemostatic Forceps Market Status (2013-2017)
    7.2 Asia Pacific Hemostatic Forceps Market Status by Manufacturers
    7.3 Asia Pacific Hemostatic Forceps Market Status by Type (2013-2017)
        7.3.1 Asia Pacific Hemostatic Forceps Sales by Type (2013-2017)
        7.3.2 Asia Pacific Hemostatic Forceps Revenue by Type (2013-2017)
    7.4 Asia Pacific Hemostatic Forceps Market Status by Downstream Industry (2013-2017)
Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry
    8.1 Latin America Hemostatic Forceps Market Status by Countries
        8.1.1 Latin America Hemostatic Forceps Sales by Countries (2013-2017)
        8.1.2 Latin America Hemostatic Forceps Revenue by Countries (2013-2017)
        8.1.3 Brazil Hemostatic Forceps Market Status (2013-2017)
        8.1.4 Argentina Hemostatic Forceps Market Status (2013-2017)
        8.1.5 Colombia Hemostatic Forceps Market Status (2013-2017)
    8.2 Latin America Hemostatic Forceps Market Status by Manufacturers
    8.3 Latin America Hemostatic Forceps Market Status by Type (2013-2017)
        8.3.1 Latin America Hemostatic Forceps Sales by Type (2013-2017)
        8.3.2 Latin America Hemostatic Forceps Revenue by Type (2013-2017)
    8.4 Latin America Hemostatic Forceps Market Status by Downstream Industry (2013-2017)
Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry
    9.1 Middle East and Africa Hemostatic Forceps Market Status by Countries
        9.1.1 Middle East and Africa Hemostatic Forceps Sales by Countries (2013-2017)
        9.1.2 Middle East and Africa Hemostatic Forceps Revenue by Countries (2013-2017)
        9.1.3 Middle East Hemostatic Forceps Market Status (2013-2017)
        9.1.4 Africa Hemostatic Forceps Market Status (2013-2017)
    9.2 Middle East and Africa Hemostatic Forceps Market Status by Manufacturers
    9.3 Middle East and Africa Hemostatic Forceps Market Status by Type (2013-2017)
        9.3.1 Middle East and Africa Hemostatic Forceps Sales by Type (2013-2017)
        9.3.2 Middle East and Africa Hemostatic Forceps Revenue by Type (2013-2017)
    9.4 Middle East and Africa Hemostatic Forceps Market Status by Downstream Industry (2013-2017)
Chapter 10 Market Driving Factor Analysis of Hemostatic Forceps
    10.1 Global Economy Situation and Trend Overview
    10.2 Hemostatic Forceps Downstream Industry Situation and Trend Overview
Chapter 11 Hemostatic Forceps Market Competition Status by Major Manufacturers
    11.1 Production Volume of Hemostatic Forceps by Major Manufacturers
    11.2 Production Value of Hemostatic Forceps by Major Manufacturers
    11.3 Basic Information of Hemostatic Forceps by Major Manufacturers
        11.3.1 Headquarters Location and Established Time of Hemostatic Forceps Major Manufacturer
        11.3.2 Employees and Revenue Level of Hemostatic Forceps Major Manufacturer
    11.4 Market Competition News and Trend
        11.4.1 Merger, Consolidation or Acquisition News
        11.4.2 Investment or Disinvestment News
        11.4.3 New Product Development and Launch
Chapter 12 Hemostatic Forceps Major Manufacturers Introduction and Market Data
    12.1 Medline 
        12.1.1 Company profile
        12.1.2 Representative Hemostatic Forceps Product
        12.1.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of Medline 
    12.2 B. Braun 
        12.2.1 Company profile
        12.2.2 Representative Hemostatic Forceps Product
        12.2.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of B. Braun 
    12.3 CareFusion 
        12.3.1 Company profile
        12.3.2 Representative Hemostatic Forceps Product
        12.3.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of CareFusion 
    12.4 Asa Dental 
        12.4.1 Company profile
        12.4.2 Representative Hemostatic Forceps Product
        12.4.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of Asa Dental 
    12.5 Sklar 
        12.5.1 Company profile
        12.5.2 Representative Hemostatic Forceps Product
        12.5.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of Sklar 
    12.6 Scanlan International 
        12.6.1 Company profile
        12.6.2 Representative Hemostatic Forceps Product
        12.6.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of Scanlan International 
    12.7 Shanghai Medical Instruments 
        12.7.1 Company profile
        12.7.2 Representative Hemostatic Forceps Product
        12.7.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of Shanghai Medical Instruments 
    12.8 Lawton 
        12.8.1 Company profile
        12.8.2 Representative Hemostatic Forceps Product
        12.8.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of Lawton 
    12.9 Hu-Friedy 
        12.9.1 Company profile
        12.9.2 Representative Hemostatic Forceps Product
        12.9.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of Hu-Friedy 
    12.10 Xinhua Surgical 
        12.10.1 Company profile
        12.10.2 Representative Hemostatic Forceps Product
        12.10.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of Xinhua Surgical 
    12.11 Towne Brothers 
        12.11.1 Company profile
        12.11.2 Representative Hemostatic Forceps Product
        12.11.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of Towne Brothers 
    12.12 Teleflex Medical 
        12.12.1 Company profile
        12.12.2 Representative Hemostatic Forceps Product
        12.12.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of Teleflex Medical 
    12.13 Delacroix Chevalier 
        12.13.1 Company profile
        12.13.2 Representative Hemostatic Forceps Product
        12.13.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of Delacroix Chevalier 
    12.14 YDM 
        12.14.1 Company profile
        12.14.2 Representative Hemostatic Forceps Product
        12.14.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of YDM 
    12.15 M A Corporation 
        12.15.1 Company profile
        12.15.2 Representative Hemostatic Forceps Product
        12.15.3 Hemostatic Forceps Sales, Revenue, Price and Gross Margin of M A Corporation 
    12.16 MedGyn Products 
    12.17 Inami 
    12.18 Ted Pella 
    12.19 Medicon eG 
    12.20 J & J Instruments 
    12.21 American Diagnostic
Chapter 13 Upstream and Downstream Market Analysis of Hemostatic Forceps
    13.1 Industry Chain of Hemostatic Forceps
    13.2 Upstream Market and Representative Companies Analysis
    13.3 Downstream Market and Representative Companies Analysis
Chapter 14 Cost and Gross Margin Analysis of Hemostatic Forceps
    14.1 Cost Structure Analysis of Hemostatic Forceps
    14.2 Raw Materials Cost Analysis of Hemostatic Forceps
    14.3 Labor Cost Analysis of Hemostatic Forceps
    14.4 Manufacturing Expenses Analysis of Hemostatic Forceps
Chapter 15 Report Conclusion
Chapter 16 Research Methodology and Reference
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Reference

Companies Included in Reports: